The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
7 reports and counting
Ginkgo Bioworks Raises $350M in Series E
Ginkgo Bioworks, a Biotech company based in 27 Drydock Avenue, Boston, MA 02210, has raised $350M in Series E at a $4.9B valuation led by Baillie Gifford, General Atlantic, Cascade Investment, T. Rowe Price, Viking Global Investors.
Ginkgo Bioworks raises $1.5B PIPE at $15B valuation
Ginkgo Bioworks raises $1.5B in PIPE at $15B valuation. Synthetic biology and organism engineering platform...
Ginkgo Bioworks raises $350M Series E at $4.9B valuation
Ginkgo Bioworks raises $350M in Series E at $4.9B valuation. Synthetic biology and organism engineering...
Ginkgo Bioworks transforms synthetic biology industry with $350M IPO at $15B valuation
Ginkgo Bioworks achieves $15B valuation through $350M IPO funding, establishing dominance in the synthetic biology market with innovative synthetic biology platform for organism design and manufacturing.
Ginkgo Bioworks Headquarters - Office Location & Address
Discover Ginkgo Bioworks's headquarters at 27 Drydock Ave, Boston, MA 02210. Synthetic biology company. Learn about the office facilities and work environment.
Umami Bioworks Headquarters - Office Location & Address
Discover Umami Bioworks's headquarters at 61 Science Park Rd, Singapore, 117525. Cell-cultured seafood production. Learn about the office facilities and work environment.
BioSynthetic Materials Raises $720M Series D for Revolutionary Synthetic Biology Technology
BioSynthetic Materials secures $720M in Series D funding at $10.8B valuation to pioneer breakthrough synthetic biology technology.
Showing 7 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.